(Yicai) Jan. 3 -- US pharma giant Eli Lilly’s Tirzepatide injection for blood sugar control and weight loss is now available ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

while Lilly's tirzepatide is used in Mounjaro and Zepbound. This year, at least seven new products containing semaglutide have been approved for sale in Laos and Russia, according to public lists ...

while Lilly's tirzepatide is used in Mounjaro and Zepbound. This year, at least seven new products containing semaglutide have been approved for sale in Laos and Russia, according to public lists of ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Eli Lilly has taken a firm stance against the sale of compounded versions of its ... any marketing or selling of unapproved versions of tirzepatide, the active ingredient in both drugs, must ...

As certain weight-loss drugs have become increasingly popular, scammers are taking notice and coming out of the woodwork to ...

The approval comes after several trials earlier this year that showed the tirzepatide-based drug is ... that makes much of its revenue through the sale of sleep apnea masks, were 4% lower on ...

The Food and Drug Administration said Thursday that the longstanding shortage of Eli Lilly’s weight-loss drug Zepbound and its Type 2 diabetes medicine Mounjaro is officially over. The ...